Clinical Trial Update: To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ferric carboxymaltose with iron sucrose in Chinese adults with iron deficiency anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Iron sucrose (iron sucrose)

Snippet

Sponsor: Vifor (International) Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2020-05-18